Regal Investment Advisors LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1559789
KENTWOOD, MI
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,608,411
+$454,999 QoQ
Shares Held
3,238
+25.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#729
of 1,735 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 16%
None 84%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Regal Investment Advisors LLC holds $10,476,569 across 7 Biotechnology names. VRTX ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
103,861 | $5,823,486 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,238 | $1,608,411 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
3,913 | $1,454,344 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,432 | $732,104 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
9,366 | $535,922 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
5,709 | $268,551 | |
| 7 | VSTM |
Verastem, Inc.
|
14,071 | $53,751 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,608,411 | 3,238 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,153,412 | 2,583 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,151,534 | 2,540 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $956,776 | 2,443 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $966,529 | 2,171 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $875,100 | 1,805 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $725,262 | 1,801 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $919,928 | 1,978 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $963,688 | 2,056 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $828,913 | 1,983 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $786,111 | 1,932 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $394,684 | 1,135 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $408,919 | 1,162 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $320,426 | 1,017 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,440,145 | 4,987 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $1,647,772 | 5,691 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,473,479 | 5,229 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $772,732 | 2,961 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $412,408 | 1,878 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $337,566 | 1,861 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $340,553 | 1,689 | Shares | Sole | 2021-08-09 | |
| 2020-12-31 | $248,393 | 1,051 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $371,306 | 1,279 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||